Mirimus

0 followers

‌

Mirimus' mission is to change the paradigm of the current drug discovery process by developing superior preclinical RNA interference (RNAi) animal models that can predict toxicities of potential drug therapies without the actual drug itself.

Industries

Headquarters

Stage

Employees

Links

Org chart

Prem Premsrirut

Founder & CEO

Prem Premsrirut

Collapse

David Eads

Chief Financial Officer

Veronica Andrews

Chief People Officer

Sean Seibel

Chief Product & Technology Officer

James Connolly

Chief Sales Officer

Ana Vasileva

VP of Translational Research, Genomics, Cell & Molecular Biology

Hui-Ting Cheng

Head Scientist

Chia-Lin Wang

Director of Genetic Engineering

Huaien Wang

Director of Cell-Based, Modeling, Cancer Biology & Genetics

Giuseppe Militello

Associate Director, RNAi Therapeutics

Michelle Riley

Project Manager

Teams

Leadership Team

7 members

Advisory Team

11 members

Scientific Research

7 members

Executives

4 members

Similar companies

REVOLUTION Medicines

4 followers

Biofourmis

4 followers

Summit Therapeutics

4 followers

Halozyme Therapeutics

3 followers

Stemline Therapeutics

3 followers

Discover companies